HuGE Literature Finder
Records
1
-
12
| BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach. Asian Pacific journal of cancer prevention : APJCP 2021 Apr 22 (4): 1171-1181. Chatterjee Koustav, De Saikat, Deb Roy Sankar, Sahu Sushil Kumar, Chakraborty Arindom, Ghatak Sandeep, Das Nilanjana, Mal Sudipa, Roy Chattopadhyay Nabanita, Das Piyanki, Reddy R Rajendra, Mukherjee Syamantak, Das Ashok Kumar, Puii Zoreng, Zomawia Eric, Singh Yengkhom Indibor, Tsering Sam, Riba Komri, Rajasubramaniam Shanmugam, Suryawanshi Amol Ratnakar, Choudhuri Tathaga |
| ATM, BCL2, and TGFß Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients. Genetic testing and molecular biomarkers 2017 Nov . Agostini Lidiane P, Stur Elaine, Garcia Fernanda M, Ventorim Diego P, Dos Reis Raquel S, Dettogni Raquel S, Dos Santos Eldamária V W, Peterle Gabriela T, Maia Lucas L, Mendes Suzanny O, de Carvalho Marcos B, Tajara Eloiza H, de Paula Flavia, Dos Santos Marcelo, da Silva Adriana M A, Louro Iúri Drumo |
| Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder. Journal of cancer research and clinical oncology 2017 Sep 143 (9): 1659-1670. Hess Jochen, Stelmach Patrick, Eisenhardt Andreas, Rübben Herbert, Reis Henning, Schmid Kurt Werner, Bachmann Hagen Sja |
| Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma. European journal of endocrinology / European Federation of Endocrine Societies 2012 Mar . Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J |
| Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma. International journal of cancer. Journal international du cancer 2011 Nov 129 (10): 2390-9. Bachmann Hagen S, Heukamp Lukas C, Schmitz Klaus J, Hilburn Caroline F, Kahl Philip, Buettner Reinhard, Nückel Holger, Eisenhardt Andreas, Rübben Herbert, Schmid Kurt Werner, Siffert Winfried, Eggert Angelika, Schramm Alexander, Schulte Johannes |
| Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in extrahepatic cholangiocarcinoma. Cancer investigation 2010 Jun 28 (5): 472-8. Fingas Christian Dominik, Katsounas Antonios, Kahraman Alisan, Siffert Winfried, Jochum Christoph, Gerken Guido, Nückel Holger, Canbay A |
| The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer. The Journal of urology 2009 Jun . Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R |
| The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009 Jun 20 (6): 1094-9. Lehnerdt G F, Franz P, Bankfalvi A, Grehl S, Kelava A, Nückel H, Lang S, Schmid K W, Siffert W, Bachmann H |
| Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma. Cancer research 2007 Oct 67 (19): 9561-7. Ruiz-Llorente Sergio, Montero-Conde Cristina, Milne Roger L, Moya Christian M, Cebrián Arancha, Letón Rocío, Cascón Alberto, Mercadillo Fátima, Landa Iñigo, Borrego Salud, Pérez de Nanclares Guiomar, Alvarez-Escolá Cristina, Díaz-Pérez José Angel, Carracedo Angel, Urioste Miguel, González-Neira Anna, Benítez Javier, Santisteban Pilar, Dopazo Joaquín, Ponder Bruce A, Robledo Mercedes, |
| The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Oct 13 (19): 5790-7. Bachmann Hagen S, Otterbach Friedrich, Callies Rainer, Nückel Holger, Bau Maja, Schmid Kurt W, Siffert Winfried, Kimmig Rain |
| Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2007 Sep 28 (9): 2008-12. Chen Kexin, Hu Zhibin, Wang Li-E, Sturgis Erich M, El-Naggar Adel K, Zhang Wei, Wei Qing |
| BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Molecular medicine (Cambridge, Mass.) 0 17 (3-4): 163-71. Fendri Ali, Kontos Christos K, Khabir Abdelmajid, Mokdad-Gargouri Raja, Scorilas Andre |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 18, 2022
- Content source: